Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Nuclear Medicine and Molecular Imaging|January 31, 2019
FDG PET imaging in multiple myeloma: implications for response assessments in clinical trialsSuchitra Sundaram, James Driscoll, Mariano Fernandez-Ulloa, et al.
Joint Commission Journal on Quality and Patient Safety|May 18, 2016
The Ask Me to Explain Campaign: A 90-Day Intervention to Promote Patient and Family Involvement in Care in a Pediatric Emergency DepartmentAlison S Tothy, Heather M Limper, James Driscoll, et al.
Nephrology (Carlton, Vic.)|March 14, 2020
Serum electrolyte dynamics in multiple myeloma patients undergoing autologous haematopoietic stem cell transplantationApoorva Anandan, Merle Kolk, Nicole Ferrari, et al.
Chemical Research in Toxicology|October 16, 2007
A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motifAmit S Kalgutkar, James Driscoll, Sabrina X Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2010
Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptorAmy S Antipas, Laura C Blumberg, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
The identification of orally bioavailable thrombopoietin agonistsMichael J Munchhof, Amy S Antipas, Laura C Blumberg, et al.
European Journal of Medicinal Chemistry|July 23, 2013
Lead identification of novel and selective TYK2 inhibitorsJun Liang, Vickie Tsui, Anne Van Abbema, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2013
Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IVMark J Mitton-Fry, Steven J Brickner, Judith C Hamel, et al.
Pageof 1